Cargando…

Pharmacokinetic profiling of quinazoline-4(3H)-one analogs as EGFR inhibitors: 3D-QSAR modeling, molecular docking studies and the design of therapeutic agents

OBJECTIVES: Breast tumor is ranked as the most common tumor type identified among women globally with over 1.7 million cases annually, representing 11.9% of the total number of cancer cases. Approved anti-breast tumor drugs exhibit several side effects and some patients develop resistance during the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdullahi, Sagiru Hamza, Uzairu, Adamu, Shallangwa, Gideon Adamu, Uba, Sani, Umar, Abdullahi Bello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taibah University 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027554/ https://www.ncbi.nlm.nih.gov/pubmed/36959916 http://dx.doi.org/10.1016/j.jtumed.2023.02.015

Ejemplares similares

QSAR modelling and molecular docking studies for anti-cancer compounds against melanoma cell line SK-MEL-2
por: Umar, Abdullahi Bello, et al.
Publicado: (2020)

QSAR analysis and molecular docking simulation of norepinephrine transporter (NET) inhibitors as anti-psychotic therapeutic agents
por: Olasupo, Sabitu Babatunde, et al.
Publicado: (2019)

In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions
por: Abdullahi, Mustapha, et al.
Publicado: (2022)

Computational modelling studies of some 1,3-thiazine derivatives as anti-influenza inhibitors targeting H1N1 neuraminidase via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions
por: Abdullahi, Mustapha, et al.
Publicado: (2022)

Computational modeling of novel quinazoline derivatives as potent epidermal growth factor receptor inhibitors
por: Ibrahim, Muhammad Tukur, et al.
Publicado: (2020)

QSAR and molecular docking studies of 1,3-dioxoisoindoline-4-aminoquinolines as potent antiplasmodium hybrid compounds
por: Mahmud, Aliyu Wappah, et al.
Publicado: (2020)

In-silico activity prediction and docking studies of some 2, 9-disubstituted 8-phenylthio/phenylsulfinyl-9h-purine derivatives as Anti-proliferative agents
por: Ibrahim, Muhammad Tukur, et al.
Publicado: (2020)

QSAR, molecular docking, design, and pharmacokinetic analysis of 2-(4-fluorophenyl) imidazol-5-ones as anti-breast cancer drug compounds against MCF-7 cell line
por: Lawal, Hadiza Abdulrahman, et al.
Publicado: (2020)

New flavone-based arylamides as potential V600E-BRAF inhibitors: Molecular docking, DFT, and pharmacokinetic properties
por: Umar, Abdullahi B., et al.
Publicado: (2023)

Molecular design of antioxidant lubricating oil additives via QSPR and analysis dynamic simulation method
por: Abdulfatai, Usman, et al.
Publicado: (2019)

QSAR Modeling and Molecular Docking Analysis of Some Active Compounds against Mycobacterium tuberculosis Receptor (Mtb CYP121)
por: Adeniji, Shola Elijah, et al.
Publicado: (2018)

Application of QSAR Method in the Design of Enhanced Antimalarial Derivatives of Azetidine-2-carbonitriles, their Molecular Docking, Drug-likeness, and SwissADME Properties
por: Ibrahim, Zakari Ya’u, et al.
Publicado: (2021)

Chemoinformatic studies on some inhibitors of dopamine transporter and the receptor targeting schizophrenia for developing novel antipsychotic agents
por: Olasupo, Sabitu Babatunde, et al.
Publicado: (2020)

QSAR, homology modeling, and docking simulation on SARS-CoV-2 and pseudomonas aeruginosa inhibitors, ADMET, and molecular dynamic simulations to find a possible oral lead candidate
por: Edache, Emmanuel Israel, et al.
Publicado: (2022)

Virtual screening and molecular dynamic simulations of the antimalarial derivatives of 2-anilino 4-amino substituted quinazolines docked against a Pf-DHODH protein target
por: Ibrahim, Zakari Ya’u, et al.
Publicado: (2022)

Obstructing Salmonella typhi's virulence in eukaryotic cells through design of its SipB protein antagonists
por: Ameji, John P., et al.
Publicado: (2022)

Virtual screening, pharmacokinetic, and DFT studies of anticancer compounds as potential V600E-BRAF kinaseinhibitors
por: Umar, Abdullahi B., et al.
Publicado: (2023)

Homology modeling, docking, and ADMET studies of benzoheterocyclic 4-aminoquinolines analogs as inhibitors of Plasmodiumfalciparum
por: Ibrahim, Zakari Y., et al.
Publicado: (2023)

Modelling PIP4K2A inhibitory activity of 1,7-naphthyridine analogues using machine learning and molecular docking studies
por: Ibrahim, Muktar Musa, et al.
Publicado: (2023)

Theoretical design of novel antimalarial agents against P. falciparum strain, Dd(2) through the QSAR modeling of synthesized 2′-substituted triclosan derivatives
por: Ibrahim, Zakari Ya'u, et al.
Publicado: (2020)

Quantitative structure-activity relationship and molecular docking studies of a series of quinazolinonyl analogues as inhibitors of gamma amino butyric acid aminotransferase
por: Abdulfatai, Usman, et al.
Publicado: (2017)

Theoretical QSAR modelling and molecular docking studies of some 4-hydroxyphenylpyruvate dioxygenase (HPPD) enzyme inhibitors potentially used as herbicides
por: Tukur, Saidu, et al.
Publicado: (2019)

A Derived QSAR Model for Predicting Some Compounds as Potent Antagonist against Mycobacterium tuberculosis: A Theoretical Approach
por: Adeniji, Shola Elijah, et al.
Publicado: (2019)

Molecular modeling and design of some β-amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles derivatives against chloroquine sensitive, 3D7 strain of Plasmodium falciparum
por: Ibrahim, Zakari Ya'u, et al.
Publicado: (2021)

Combining docking, molecular dynamics simulations, AD-MET pharmacokinetics properties, and MMGBSA calculations to create specialized protocols for running effective virtual screening campaigns on the autoimmune disorder and SARS-CoV-2 main protease
por: Edache, Emmanuel Israel, et al.
Publicado: (2023)

In silico studies of piperazine derivatives as potent anti-proliferative agents against PC-3 prostate cancer cell lines
por: Ikwu, Fabian A., et al.
Publicado: (2020)

Computational studies of a series of 2-substituted phenyl-2-oxo-, 2-hydroxyl- and 2-acylloxyethylsulfonamides as potent anti-fungal agents
por: Isyaku, Yusuf, et al.
Publicado: (2020)

Quantum modelling and molecular docking evaluation of some selected quinoline derivatives as anti-tubercular agents
por: Adeniji, Shola Elijah, et al.
Publicado: (2020)

In silico analysis of noscapine compounds as anti-tumor agents targeting the tubulin receptor
por: Nulamuga, Benson, et al.
Publicado: (2022)

In silico prediction of nuclear receptor binding to polychlorinated dibenzofurans and its implication on endocrine disruption in humans and wildlife
por: Akinola, Lukman K., et al.
Publicado: (2021)

Quinazoline analogues as cytotoxic agents; QSAR, docking, and in silico studies
por: Emami, Leila, et al.
Publicado: (2021)

3D,2D-QSAR study and docking of novel quinazolines as potential target drugs for osteosarcoma
por: Lian, Zheng, et al.
Publicado: (2023)

2D-QSAR, molecular docking, drug-likeness, and ADMET/pharmacokinetic predictions of some non-small cell lung cancer therapeutic agents
por: Ibrahim, M.T., et al.
Publicado: (2022)

Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer’s disease treatment
por: Uzairu, Sani Muhammad, et al.
Publicado: (2022)

Benzo[g]quinazolines as antifungal against candidiasis: Screening, molecular docking, and QSAR investigations
por: Abuelizz, Hatem A., et al.
Publicado: (2023)

3D-QSAR Study of Combretastatin A-4 Analogs Based on Molecular Docking
por: Jin, Yinghua, et al.
Publicado: (2011)

Combined 3D-QSAR modeling and molecular docking study on multi-acting quinazoline derivatives as HER2 kinase inhibitors
por: Mirzaie, Sako, et al.
Publicado: (2013)

Binding profile of protein–ligand inhibitor complex and structure based design of new potent compounds via computer-aided virtual screening
por: Shallangwa, Gideon Adamu, et al.
Publicado: (2021)

Molecular Docking and QSAR Study of 2-Benzoxazolinone, Quinazoline and Diazocoumarin Derivatives as Anti-HIV-1 Agents
por: Faghihi, Kamyar, et al.
Publicado: (2019)

QSAR-Based Models for Designing Quinazoline/Imidazothiazoles/Pyrazolopyrimidines Based Inhibitors against Wild and Mutant EGFR
por: Chauhan, Jagat Singh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hm8tlak96cci9e775rfg1unvup